中華民國血液病學會 - 血液疾病研究及治療

109年7月11日(六)14:20:00

自行前往

Time	Topic	Speaker	Moderator
14:20-14:30	Opening Remarks	王銘崇醫師高雄長庚
14:30-15:05	Pathogenesis and diagnosis of CLL -Molecular and cytogenetic risk factors -Clinical impact of high risk factors	黃泰中醫師臺大醫院	王銘崇醫師高雄長庚
15:05-15:15	Discussion
15:15-15:50	The mechanism of BTK Inhibitor and Bcl2 Inhibitor Resistance	黃威翰醫師花蓮慈濟	王銘崇醫師高雄長庚
15:50-16:00	Discussion
16:00-16:15	Break
16:15-16:50	Current treatment algorithm for CLL and clinical trial spotlight: A resource for clinicians -Treatment Strategy for CLL and R/R CLL -New and future for R/R CLL treatment	王浩元醫師台北榮總	譚傳德醫師和信醫院
16:50-17:00	Discussion
17:00-17:35	The role of minimum residual disease in CLL treatment	韓紹民醫師台大癌醫中心	譚傳德醫師和信醫院
17:35-17:45	Discussion
17:45-19:30	Dinner with discussion	譚傳德醫師和信醫院